title: The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS).
authors.forename: Marjorie
authors.initials: M
authors.lastname: Boissinot
authors.forename: Richard
authors.initials: R
authors.lastname: Garand
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hamidou
authors.forename: Sylvie
authors.initials: S
authors.lastname: Hermouet
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution; D000753:Anemia, Refractory / Q000145:classification / Q000201:enzymology / Q000235:genetics*; D000756:Anemia, Sideroblastic / Q000145:classification / Q000201:enzymology / Q000235:genetics*; D017931:DNA Primers; D005260:Female; D006801:Humans; D053614:Janus Kinase 2; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D013920:Thrombocythemia, Essential / Q000145:classification / Q000201:enzymology / Q000235:genetics*
chemical_list: D017931:DNA Primers; D011518:Proto-Oncogene Proteins; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2